Cargando…
Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
Non-alcoholic fatty liver (NAFLD) is a widespread disease with various complications including Non-alcoholic steatohepatitis (NASH) that could lead to cirrhosis and ultimately hepatocellular carcinoma (HCC). Up till now there is no FDA approved drug for treatment of NAFLD. Flavonoids such as Rhamnet...
Autores principales: | Shatta, Mahmoud A., El-Derany, Marwa O., Gibriel, Abdullah A., El-Mesallamy, Hala O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267014/ https://www.ncbi.nlm.nih.gov/pubmed/36495373 http://dx.doi.org/10.1007/s11010-022-04619-6 |
Ejemplares similares
-
Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis
por: El-Derany, Marwa O.
Publicado: (2020) -
Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms
por: El-Derany, Marwa O., et al.
Publicado: (2022) -
Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C
por: El-Derany, M. O., et al.
Publicado: (2016) -
Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2
por: Novo Belchor, Mariana, et al.
Publicado: (2017) -
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
por: Caracciolo, Daniele, et al.
Publicado: (2022)